Amanda Cano

Statistics

Publications

Citations

4.8K

H-Index

Active since

2016

Affiliations

Biomedical Research Networking Center on Neurodegenerative Diseases(Current)

Universitat de Barcelona

Instituto de Salud Carlos III

Institut de Nanociència i Nanotecnologia de la Universitat de Barcelona

Fundació ACE

Amanda Cano is an author at Biomedical Research Networking Center on Neurodegenerative Diseases specializing in neuroscience, alzheimer disease, and dementia.

ORCID

Publications per year

2016–2025

Publications

New insights into the genetic etiology of Alzheimer’s disease and related dementias

Céline Bellenguez, Fahri Küçükali, Iris E. Jansen et al. · Nature Genetics · 2022 · 2.5K citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model

Amanda Cano, Miren Ettcheto, Jui-Hsien Chang et al. · Journal of Controlled Release · 2019 · 331 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization

Elena Sánchez‐López, Miren Ettcheto, María Antonia Egea et al. · Journal of Nanobiotechnology · 2018 · 284 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

PEGylated PLGA nanospheres optimized by design of experiments for ocular administration of dexibuprofen—in vitro, ex vivo and in vivo characterization

Elena Sánchez‐López, M.A. Egea, Amanda Cano et al. · Colloids and Surfaces B Biointerfaces · 2016 · 147 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Current Advances in The Development of Novel Polymeric Nanoparticles for The Treatment of Neurodegenerative Diseases

Amanda Cano, Elena Sánchez‐López, Miren Ettcheto et al. · Nanomedicine · 2020 · 137 citations · Full text

Pharmacy, Neuroscience, Pharmaceutics +17

1–5 of 46